ROLAPITANT |
ROLAPITANT : Antagonist of TACR1
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| TACR1 |
|
Antagonist
up to 100 nM
Selectivity
In Vitro Selectivity Assessment
Potency Assay Off-Target:
Selectivity within target family: >1000-fold for the human
NK1 receptor compared to the human NK2 an ...
Potency Cellular
In Vitro
TACR1
Mode of Action: Antagonist
Structure-Activity-Relationship data available? No
DOI Reference: 10.1016/j.pbb.2012.03.021
In Vivo Validations
Gerbils
Dose: 0.3 mg/kg, 1.0 mg/Kg IV, o.3 mg/Kg PO
Route of delivery:
Intravenous, Oral
Target engagement assay:
Intravenous rolapitant (0.3 and 1 mg/kg) dose-dependently blocked the foot tapping induced byGR-73632 with complete blockade observed at 1 mg/kg, iv.
DOI Reference: 10.1016/j.pbb.2012.03.021
Chemical Information
| Molecular Formula | C25H26F6N2O2 |
| InChI | InChI=1S/C25H26F6N2O2/c1-16(17-11-19(24(26,27)28)13-20(12-17)25(29,30)31)35-15-23(18-5-3-2-4-6-18)10-9-22(14-32-23)8-7-21(34)33-22/h2-6,11-13,16,32H,7-10,14-15H2,1H3,(H,33,34)/t16-,22-,23-/m1/s1 |
| Molecular weight | 500.19 Da |
| AlogP | 0.0 |
| HBond acceptors | 4 |
| HBond donors | 2 |
| Atoms | 61 |